title: Emerging pharmacological therapy for functional dyspepsia.
abstract: Functional dyspepsia (FD) is a multifactorial disease with complex underlying pathophysiology. To date, there is no established treatment for FD. This review summarizes recent progress in pharmacological therapy for the disease. A newly developed drug, acotiamide, is expected to improve symptoms of postprandial distress syndrome. Herbal medicines are also expected to become options for FD treatment.
authors.affiliation: Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan. mhojo@juntendo.ac.jp.
authors.forename: Mariko
authors.initials: M
authors.lastname: Hojo
authors.affiliation: Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.
authors.forename: Akihito
authors.initials: A
authors.lastname: Nagahara
authors.affiliation: Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.
authors.forename: Daisuke
authors.initials: D
authors.lastname: Asaoka
authors.affiliation: Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.
authors.forename: Sumio
authors.initials: S
authors.lastname: Watanabe
keywords: Acetylcholine; Acotiamide rikkunshito; Itopride; Tandospirone